美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apimeds Pharmaceutical U.S, Inc.

1.31

+0.07005.65%

盤後：1.28-0.0300-2.29%19:47 EST

成交量：3.55萬

成交額：4.57萬

市值：1,647.45萬

市盈率：-3.20

高：1.38

開：1.18

低：1.18

收：1.24

52周最高：4.03

52周最低：0.9510

股本：1,257.60萬

流通股本：337.50萬

量比：0.08

換手率：1.05%

股息：- -

股息率：- -

每股收益(TTM):-0.4100

每股收益(LYR):-0.1759

淨資產收益率：-144.99%

總資產收益率：-69.29%

市淨率：2.02

市盈率(LYR):-7.45

資料載入中...

總覽公司新聞資訊公告

Apimeds Pharmaceuticals Us, Inc.股價拉升11.36% 市值跌3.04萬美元

Apimeds製藥與LŌKahi Therapeutics宣佈FDA就Lt‑100（Apitox）召開C類會議

Apimeds Pharmaceuticals Us, Inc.盤中異動急速拉升8.11%

E.f. Hutton建言Apimeds與Mindwave戰略合併，實現生物科技與人工智能金融創新的協同發展

Apimeds Pharmaceutical U.S, Inc.與Mindwave Innovations宣佈完成1億美元PIPE孖展並激活1000個比特幣以推動基於人工智能的收益生成策略

Apimeds與Mindwave宣佈合併，將生物技術增長與基於人工智能的數字財政收益生成整合，獲得1億美元的PIPE孖展

Apimeds Pharmaceuticals Us, Inc.盤中異動股價大漲5.02%

Apimeds Pharmaceuticals Us, Inc.盤中異動早盤股價大漲6.28%報2.37美元

嗡嗡聲--美國股票走勢-疫苗製造商、NextDecade、阿拉斯加航空集團

嗡嗡聲--美國股票走勢-Lennox, Camtek, J.M. Smucker

嗡嗡聲--美國股票走勢-Adobe , GE Vernova, CleanCore

BUZZ-因 FDA 支持加快非阿片類止痛藥的審批速度，Apimeds 製藥公司業績大增

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/APUS/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"APUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","market":"US","secType":"STK","nameCN":"Apimeds Pharmaceutical  U.S, Inc.","latestPrice":1.31,"timestamp":1771966800000,"preClose":1.24,"halted":0,"volume":35476,"hourTrading":{"tag":"盘后","latestPrice":1.28,"preClose":1.31,"latestTime":"19:47 EST","volume":808,"amount":1011.19,"timestamp":1771980463805,"change":-0.03,"changeRate":-0.022901,"amplitude":0.068015},"delay":0,"changeRate":0.05645161290322586,"floatShares":3375000,"shares":12575983,"eps":-0.41,"marketStatus":"已收盤","change":0.07,"latestTime":"02-24 16:00:00 EST","open":1.18,"high":1.3786,"low":1.18,"amount":45694.4396356,"amplitude":0.160161,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.41,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1772010000000},"marketStatusCode":5,"adr":0,"listingDate":1746763200000,"exchange":"AMEX","adjPreClose":1.24,"preHourTrading":{"tag":"盘前","latestPrice":1.29,"preClose":1.24,"latestTime":"09:04 EST","volume":210,"amount":271.179993,"timestamp":1771941867466,"change":0.05,"changeRate":0.040323,"amplitude":0.001129},"postHourTrading":{"tag":"盘后","latestPrice":1.28,"preClose":1.31,"latestTime":"19:47 EST","volume":808,"amount":1011.19,"timestamp":1771980463805,"change":-0.03,"changeRate":-0.022901,"amplitude":0.068015},"volumeRatio":0.076022},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","floatShares":3375000,"roa":"-69.29%","roe":"-144.99%","lyrEps":-0.175862,"volumeRatio":0.076022,"shares":12575983,"dividePrice":0,"high":1.3786,"amplitude":0.160161,"preClose":1.24,"low":1.18,"week52Low":0.951,"pbRate":"2.02","week52High":4.031,"institutionHeld":0,"latestPrice":1.31,"eps":-0.41,"divideRate":0,"volume":35476,"delay":0,"ttmEps":-0.41,"open":1.18,"prevYearClose":1.64,"prevWeekClose":1.3897,"prevMonthClose":1.85,"prevQuarterClose":1.64,"fiveDayClose":1.15,"twentyDayClose":1.6,"sixtyDayClose":1.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APUS\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APUS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APUS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APUS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APUS","date":"2025-12-01","current":-3.195122,"percent":0.642384,"low":-37.866629,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"high":-4.754876,"avg":-11.953693,"sd":7.073766,"marketCap":36470350},"quantilePoints":[{"date":"2025-02-21","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-02-28","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-03-05","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-05-09","current":-18.309826,"twenty":-34.716764,"median":-34.716764,"eighty":-33.299512,"marketCap":25450475},{"date":"2025-05-16","current":-14.148502,"twenty":-34.716764,"median":-34.008138,"eighty":-15.063993,"marketCap":19666276},{"date":"2025-05-23","current":-14.074662,"twenty":-34.716764,"median":-18.309826,"eighty":-14.306662,"marketCap":21054484},{"date":"2025-05-30","current":-13.387434,"twenty":-34.716764,"median":-15.063993,"eighty":-14.061031,"marketCap":20026450},{"date":"2025-06-06","current":-14.702962,"twenty":-34.716764,"median":-14.800251,"eighty":-13.996937,"marketCap":21994367},{"date":"2025-06-13","current":-14.314495,"twenty":-34.716764,"median":-14.564634,"eighty":-14.061031,"marketCap":21413253},{"date":"2025-06-20","current":-13.774354,"twenty":-33.866413,"median":-14.548195,"eighty":-14.0474,"marketCap":20605249},{"date":"2025-06-27","current":-13.296895,"twenty":-33.299512,"median":-14.356338,"eighty":-13.867215,"marketCap":19891011},{"date":"2025-07-03","current":-13.774354,"twenty":-27.303638,"median":-14.27266,"eighty":-13.727614,"marketCap":20605249},{"date":"2025-07-11","current":-14.006506,"twenty":-17.177946,"median":-14.161274,"eighty":-13.727614,"marketCap":20952529},{"date":"2025-07-18","current":-13.851738,"twenty":-15.354982,"median":-14.154888,"eighty":-13.727614,"marketCap":20721009},{"date":"2025-07-25","current":-16.173259,"twenty":-16.219689,"median":-14.161274,"eighty":-13.727614,"marketCap":24193804},{"date":"2025-08-01","current":-13.464818,"twenty":-16.219689,"median":-14.199966,"eighty":-13.727614,"marketCap":20142210},{"date":"2025-08-08","current":-12.14929,"twenty":-16.049445,"median":-14.148502,"eighty":-13.573156,"marketCap":18174293},{"date":"2025-08-15","current":-12.265366,"twenty":-15.710284,"median":-14.056061,"eighty":-13.418388,"marketCap":18347933},{"date":"2025-08-22","current":-7.697345,"twenty":-15.447843,"median":-14.006506,"eighty":-13.015991,"marketCap":28547481},{"date":"2025-08-29","current":-6.307075,"twenty":-15.306558,"median":-13.929122,"eighty":-12.721932,"marketCap":23391328},{"date":"2025-09-05","current":-6.307075,"twenty":-15.146611,"median":-13.929122,"eighty":-12.474303,"marketCap":23391328},{"date":"2025-09-12","current":-6.578348,"twenty":-15.038217,"median":-13.851738,"eighty":-12.234412,"marketCap":24397407},{"date":"2025-09-19","current":-6.205348,"twenty":-14.9276,"median":-13.774354,"eighty":-7.507455,"marketCap":23014048},{"date":"2025-09-26","current":-6.049367,"twenty":-14.889578,"median":-13.773581,"eighty":-6.849619,"marketCap":22435553},{"date":"2025-10-03","current":-5.832349,"twenty":-14.826776,"median":-13.69697,"eighty":-6.578348,"marketCap":21630690},{"date":"2025-10-10","current":-6.307075,"twenty":-14.675296,"median":-13.542202,"eighty":-6.472551,"marketCap":23391328},{"date":"2025-10-17","current":-6.239257,"twenty":-14.561346,"median":-13.50351,"eighty":-6.415584,"marketCap":23139808},{"date":"2025-10-24","current":-5.879822,"twenty":-14.548195,"median":-13.387434,"eighty":-6.358617,"marketCap":21806754},{"date":"2025-10-31","current":-6.917438,"twenty":-14.538909,"median":-13.039206,"eighty":-6.374893,"marketCap":25655005},{"date":"2025-11-07","current":-8.524725,"twenty":-14.481047,"median":-12.845746,"eighty":-6.381675,"marketCap":31616021},{"date":"2025-11-14","current":-9.460613,"twenty":-14.381444,"median":-12.652286,"eighty":-6.415584,"marketCap":35086992},{"date":"2025-11-21","current":-5.852155,"twenty":-14.312928,"median":-12.458826,"eighty":-6.415584,"marketCap":30182359},{"date":"2025-11-28","current":-7.071353,"twenty":-14.306662,"median":-12.304058,"eighty":-6.374893,"marketCap":36470350},{"date":"2025-12-01","current":-7.071353,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"marketCap":36470350}],"updateTime":1771982783519},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APUS\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611670891","title":"Apimeds Pharmaceuticals Us, Inc.股價拉升11.36% 市值跌3.04萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611670891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611670891?lang=zh_tw&edition=fundamental","pubTime":"2026-02-14 00:17","pubTimestamp":1770999458,"startTime":"0","endTime":"0","summary":"北京时间2026年02月14日00时17分，Apimeds Pharmaceuticals Us, Inc.股票出现波动，股价快速拉升11.36%。Apimeds Pharmaceuticals Us, Inc.股票所在的制药行业中，整体涨幅为1.35%。Apimeds Pharmaceuticals Us, Inc.公司简介：Apimeds Pharmaceuticals Us Inc 是一家临床阶段公司。Apitox目前由Apimeds Inc.在韩国以Apitoxin的名称进行营销和销售，用于治疗骨关节炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260214001738a6f861ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260214001738a6f861ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APUS","LU2089284900.SGD","LU2089283258.USD","LU0557290698.USD","LU2023251221.USD","LU0267386448.USD","BK4504","LU0795875086.SGD","LU1162221912.USD","LU0912757837.SGD","LU1989772923.USD","LU2028103732.USD","LU0098860793.USD","LU1244550221.USD","LU1989772840.SGD","BK4588","LU0158827948.USD","BK4581","LU1244550494.USD","LU1720051108.HKD","LU1074936037.SGD","LU1732800096.USD","LU1791710400.SGD","LU2357305700.SGD","LU0006306889.USD","BK4516","LU0320765646.SGD","LU2133065610.SGD","LU0971096721.USD","LU0795875169.SGD","LU0225283273.USD","LU0528227936.USD","LU0106261372.USD","LU2347655156.SGD","LU0158827781.USD","LU0314104364.USD","LU1720051017.SGD","LU0882574139.USD","LU1732799900.SGD","LU2271345857.HKD","BK4585","LU1668664300.SGD","BK4127","LU0234570918.USD","BK4139","LU1548497426.USD","LU1791710582.SGD","LU1244550577.SGD","IE00BKVL7J92.USD","BK4534"],"gpt_icon":0},{"id":"1135354753","title":"Apimeds製藥與LŌKahi Therapeutics宣佈FDA就Lt‑100（Apitox）召開C類會議","url":"https://stock-news.laohu8.com/highlight/detail?id=1135354753","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135354753?lang=zh_tw&edition=fundamental","pubTime":"2026-02-12 05:52","pubTimestamp":1770846761,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals与LŌKahi Therapeutics联合宣布，已与美国食品药品监督管理局（FDA）就Lt‑100（Apitox）药物安排C类会议。此次会议标志着该候选药物研发进程迈出关键一步。\nC类会议通常旨在解决药物开发过程中的特定问题，为后续临床研究或上市申请提供指导。两家公司通过此次会议寻求与FDA就Lt‑100的开发策略进行深入沟通。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"gpt_icon":0},{"id":"2601868538","title":"Apimeds Pharmaceuticals Us, Inc.盤中異動 急速拉升8.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601868538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601868538?lang=zh_tw&edition=fundamental","pubTime":"2026-01-05 23:19","pubTimestamp":1767626344,"startTime":"0","endTime":"0","summary":"北京时间2026年01月05日23时19分，Apimeds Pharmaceuticals Us, Inc.股票出现波动，股价急速上涨8.11%。Apimeds Pharmaceuticals Us, Inc.股票所在的制药行业中，整体跌幅为2.10%。其相关个股中，脑再生科技、Redhill Biopharma Ltd、Caring Brands, Inc.涨幅较大，Redhill Biopharma Ltd、Akanda Corp.、Cbdmd, Inc.较为活跃，换手率分别为407.22%、26.50%、6.65%，振幅较大的相关个股有Ironwood医药、脑再生科技、Caring Brands, Inc.，振幅分别为11.83%、11.05%、11.05%。Apimeds Pharmaceuticals Us, Inc.公司简介：Apimeds Pharmaceuticals Us Inc 是一家临床阶段公司。Apitox目前由Apimeds Inc.在韩国以Apitoxin的名称进行营销和销售，用于治疗骨关节炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105231904953c0534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105231904953c0534&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0006306889.USD","LU0106831901.USD","LU0314104364.USD","LU2357305700.SGD","LU2089284900.SGD","BK4504","LU1791710400.SGD","BK4581","LU1720051108.HKD","IE00BKVL7J92.USD","LU0158827948.USD","BK4139","LU2028103732.USD","APUS","LU1732799900.SGD","LU1244550494.USD","LU2111349929.HKD","BK4534","LU2133065610.SGD","LU0320765646.SGD","BK4588","LU0882574139.USD","LU0912757837.SGD","LU1363072403.SGD","LU0267386448.USD","LU0234570918.USD","LU2271345857.HKD","LU1989772923.USD","BK4516","LU0106261372.USD","LU1162221912.USD","LU0971096721.USD","LU0158827781.USD","LU0557290698.USD","LU1244550577.SGD","LU0098860793.USD","IE00BZ1G4Q59.USD","LU0795875086.SGD","LU0528227936.USD","LU1244550221.USD","LU1720051017.SGD","LU1732800096.USD","LU1989772840.SGD","BK4127","LU1668664300.SGD","LU1074936037.SGD","LU2023251221.USD","LU0795875169.SGD","LU2347655156.SGD","BK4585"],"gpt_icon":0},{"id":"1139835738","title":"E.f. Hutton建言Apimeds與Mindwave戰略合併，實現生物科技與人工智能金融創新的協同發展","url":"https://stock-news.laohu8.com/highlight/detail?id=1139835738","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139835738?lang=zh_tw&edition=fundamental","pubTime":"2025-12-17 21:01","pubTimestamp":1765976494,"startTime":"0","endTime":"0","summary":"E.f. Hutton建言Apimeds与Mindwave战略合并，实现生物科技与人工智能金融创新的协同发展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"gpt_icon":0},{"id":"1189663685","title":"Apimeds Pharmaceutical U.S, Inc.與Mindwave Innovations宣佈完成1億美元PIPE孖展並激活1000個比特幣以推動基於人工智能的收益生成策略","url":"https://stock-news.laohu8.com/highlight/detail?id=1189663685","media":"美股速递","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189663685?lang=zh_tw&edition=fundamental","pubTime":"2025-12-10 23:00","pubTimestamp":1765378812,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceutical U.S, Inc.与Mindwave Innovations宣布完成1亿美元PIPE融资，并激活1000个比特币以推动基于人工智能的收益生成策略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"gpt_icon":0},{"id":"1173159593","title":"Apimeds與Mindwave宣佈合併，將生物技術增長與基於人工智能的數字財政收益生成整合，獲得1億美元的PIPE孖展","url":"https://stock-news.laohu8.com/highlight/detail?id=1173159593","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173159593?lang=zh_tw&edition=fundamental","pubTime":"2025-12-01 22:26","pubTimestamp":1764599218,"startTime":"0","endTime":"0","summary":"Apimeds与Mindwave宣布合并，将生物技术增长与基于人工智能的数字财政收益生成整合，获得1亿美元的PIPE融资","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APUS"],"gpt_icon":0},{"id":"2583632112","title":"Apimeds Pharmaceuticals Us, Inc.盤中異動 股價大漲5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583632112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583632112?lang=zh_tw&edition=fundamental","pubTime":"2025-11-15 00:27","pubTimestamp":1763137640,"startTime":"0","endTime":"0","summary":"北京时间2025年11月15日00时27分，Apimeds Pharmaceuticals Us, Inc.股票出现波动，股价大幅上涨5.02%。Apimeds Pharmaceuticals Us, Inc.股票所在的制药行业中，整体涨幅为0.01%。其相关个股中，Alvotech C/Wts 、Avadel Pharmaceuticals Plc、Talphera, Inc.涨幅较大，Akanda Corp.、Avadel Pharmaceuticals Plc、Hims & Hers Health, Inc.较为活跃，换手率分别为958.08%、8.01%、6.51%，振幅较大的相关个股有Caring Brands, Inc.、Akanda Corp.、Talphera, Inc.，振幅分别为27.27%、21.71%、15.24%。Apimeds Pharmaceuticals Us, Inc.公司简介：Apimeds Pharmaceuticals Us Inc 是一家临床阶段公司。Apitox目前由Apimeds Inc.在韩国以Apitoxin的名称进行营销和销售，用于治疗骨关节炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115002720a6f9f103&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115002720a6f9f103&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0158827948.USD","APUS","LU0557290698.USD","LU2111349929.HKD","IE00BZ1G4Q59.USD","LU0006306889.USD","LU0106261372.USD","LU0234570918.USD","BK4139","BK4127","LU0971096721.USD","LU1244550221.USD","LU2028103732.USD","IE00BKVL7J92.USD","LU1162221912.USD","LU0158827781.USD","LU0098860793.USD","LU1074936037.SGD","LU2089283258.USD","LU1363072403.SGD","BK4581","LU1720051017.SGD","LU1244550494.USD","LU1732800096.USD","LU1732799900.SGD","BK4516","LU0314104364.USD","LU0106831901.USD","LU2357305700.SGD","BK4585","LU1668664300.SGD","LU0795875169.SGD","LU0225283273.USD","LU1548497426.USD","LU0320765646.SGD","LU1720051108.HKD","LU1989772923.USD","LU2133065610.SGD","LU0267386448.USD","LU2347655156.SGD","LU0795875086.SGD","BK4588","BK4534","LU2023251221.USD","LU2089284900.SGD","LU0912757837.SGD","LU1989772840.SGD","LU0882574139.USD","LU1244550577.SGD","BK4504"],"gpt_icon":0},{"id":"2582366021","title":"Apimeds Pharmaceuticals Us, Inc.盤中異動 早盤股價大漲6.28%報2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582366021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582366021?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 22:54","pubTimestamp":1762786488,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时54分，Apimeds Pharmaceuticals Us, Inc.股票出现异动，股价大幅拉升6.28%。截至发稿，该股报2.37美元/股，成交量1613股，换手率0.01%，振幅0.00%。Apimeds Pharmaceuticals Us, Inc.股票所在的制药行业中，整体涨幅为3.60%。Apimeds Pharmaceuticals Us, Inc.公司简介：Apimeds Pharmaceuticals Us Inc 是一家临床阶段公司。在生物药品商业交易领域，从事向客户提供生物药品Apitox的制药业务。Apitox目前由Apimeds Inc.在韩国以Apitoxin的名称进行营销和销售，用于治疗骨关节炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022544894fb9b89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022544894fb9b89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0971096721.USD","BK4139","LU0106831901.USD","LU0882574139.USD","LU1720051017.SGD","BK4585","LU2023251221.USD","LU0098860793.USD","LU0006306889.USD","LU1363072403.SGD","BK4588","LU1732800096.USD","LU1244550494.USD","LU1668664300.SGD","LU0912757837.SGD","LU0267386448.USD","LU0320765646.SGD","LU1732799900.SGD","LU1989772840.SGD","LU2357305700.SGD","BK4127","BK4516","LU0314104364.USD","LU2133065610.SGD","LU2028103732.USD","IE00BKVL7J92.USD","LU1074936037.SGD","LU2089284900.SGD","BK4581","IE00BZ1G4Q59.USD","LU0158827781.USD","LU0234570918.USD","LU0557290698.USD","APUS","LU2271345857.HKD","BK4534","BK4504","LU0795875086.SGD","LU2089283258.USD","LU1244550577.SGD","LU0795875169.SGD","LU1548497426.USD","LU1162221912.USD","LU1244550221.USD","LU2347655156.SGD","LU0225283273.USD","LU0106261372.USD","LU1989772923.USD","LU1720051108.HKD","LU0158827948.USD"],"gpt_icon":0},{"id":"2567905769","title":"嗡嗡聲--美國股票走勢-疫苗製造商、NextDecade、阿拉斯加航空集團","url":"https://stock-news.laohu8.com/highlight/detail?id=2567905769","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567905769?lang=zh_tw&edition=fundamental","pubTime":"2025-09-13 01:40","pubTimestamp":1757698811,"startTime":"0","endTime":"0","summary":"美国东部时间13:29，道琼斯工业平均指数.DJI下跌0.35%，报45,946.04点；标准普尔500指数.SPX上涨0.05%，报6,591.00点；纳斯达克综合指数.IXIC上涨0.45%，报22,141.59点。标准普尔 500 指数.PG.INX 百分比涨幅前三名是 ** 华纳兄弟发现公司 WBD.OQ，上涨 17.5% ** 特斯拉公司 TSLA.OQ，上涨 6.7% ** 派拉蒙天空舞蹈公司 PSKY.OQ，上涨 4.1% ** 纳斯达克综合指数.IXIC，上涨 0.45%，报 22,141.59 点。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nL3S3UZ16W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","ANEB","BNTX","APUS","ARRY","LII","OEC","HOTH","GEV","ISPC","AGAE","OXM","OPAD","RNA","GCTK","RH","RENT","BW","PFE","TECH","00200","TT","FICO","WBD","ALK","COCP","ANET","STG","02018","XTIA","PRE","SNVD.UK","NEXT","VNCE","SJM","VCIG","AEI","NXTT","BGSF","OPI","CAMT","PSKY","MSC"],"gpt_icon":1},{"id":"2566974966","title":"嗡嗡聲--美國股票走勢-Lennox, Camtek, J.M. Smucker","url":"https://stock-news.laohu8.com/highlight/detail?id=2566974966","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566974966?lang=zh_tw&edition=fundamental","pubTime":"2025-09-12 21:08","pubTimestamp":1757682515,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nL3S3UZ0V2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2417539215.USD","LU1691799644.USD","GEV","LU2413666699.HKD","IE00BN29S564.USD","LU1923623000.USD","LU1815333072.USD","LU1551013425.SGD","LU0289960550.SGD","LU1116320901.HKD","RNA","BK4141","NVD2.UK","NVDY","LU0823414551.USD","SGXZ23171101.USD","NVIW.SI","LU0353189680.USD","BK4529","NVDS.UK","2NVD.UK","LU0198837287.USD","LU2357305700.SGD","APUS","HOTH","SJM","RH","LII","LU2111349929.HKD","3NVD.UK","SNVD.UK","NVD3.UK","LU0070217475.USD","LU1983260115.SGD","NVDD","SG9999015952.SGD","NVDU","LU2458330243.SGD","NVDS","LU2237957902.USD","NVDX","LU2272731865.HKD","BK4566","NVD","IE00BD6J9T35.USD"],"gpt_icon":1},{"id":"2566765849","title":"嗡嗡聲--美國股票走勢-Adobe , GE Vernova, CleanCore","url":"https://stock-news.laohu8.com/highlight/detail?id=2566765849","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566765849?lang=zh_tw&edition=fundamental","pubTime":"2025-09-12 19:32","pubTimestamp":1757676736,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nL3T3UZ0RA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1814569148.SGD","LU0861579265.USD","LU2237957811.SGD","LU1116320901.HKD","NVDX","NVDY","GEV","LU0820561909.HKD","LU0276348264.USD","LU2473716301.USD","LU2491049909.HKD","NVD3.UK","NVDS","LU0107464264.USD","3NVD.UK","LU0109391861.USD","IE00BFXG0V08.USD","LU1804176565.USD","LU2506951792.HKD","NVD","ZONE","APUS","ADBE","LU0444973449.USD","NVD2.UK","NVDS.UK","LU1721428933.USD","LU1791710582.SGD","LU0070217475.USD","LU1861220033.SGD","SGXZ99366536.SGD","NVDD","SNVD.UK","IE00BYXW3230.USD","RH","LU0708994859.HKD","LU1917777945.USD","LU0823421416.USD","NVDU","LU0210536198.USD","2NVD.UK","LU1035775433.USD","LU2471134523.USD","NVIW.SI","LU1066051498.USD","LU2250418816.HKD","LU1815336760.USD"],"gpt_icon":1},{"id":"2566751369","title":"BUZZ-因 FDA 支持加快非阿片類止痛藥的審批速度，Apimeds 製藥公司業績大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2566751369","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566751369?lang=zh_tw&edition=fundamental","pubTime":"2025-09-12 19:13","pubTimestamp":1757675589,"startTime":"0","endTime":"0","summary":"BUZZ-因 FDA 支持加快非阿片类止痛药的审批速度，Apimeds 制药公司业绩大增9月12日 - ** 药物开发商Apimeds Pharmaceuticals APUS.A股价盘前上涨26.5%，至2.48美元** 周四晚些时候，该公司对 。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nL3T3UZ0QG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}]}}